Coastal Investment Advisors, Inc. Celldex Therapeutics, Inc. Transaction History

Coastal Investment Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 05, 2020	SELL	$2.11 - $2.8 $4,061 - $5,390	-1,925 Closed	0 $0
Q3 2019 Oct 18, 2019	SELL	$2.05 - $2.75 $9,893 - $13,271	-4,826 Reduced 71.49%	1,925 $4,000
Q2 2019 Aug 01, 2019	BUY	$2.43 - $5.09 $16,404 - $34,362	6,751 New	6,751 $17,000

204

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.14B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.